Back to Journals » Drug Design, Development and Therapy » Volume 4
![](https://www.dovepress.com/cr_data/cache/journal_image/19/cope/thumb_100_1000_100.jpg)
Drug Design, Development and Therapy
ISSN: 1177-8881
- View all (4228)
- Volume 18, 2024 (189)
- Volume 17, 2023 (283)
- Volume 16, 2022 (316)
- Volume 15, 2021 (399)
- Volume 14, 2020 (477)
- Volume 13, 2019 (387)
- Volume 12, 2018 (382)
- Volume 11, 2017 (330)
- Volume 10, 2016 (374)
- Volume 9, 2015 (543)
- Volume 8, 2014 (231)
- Volume 7, 2013 (143)
- Volume 6, 2012 (42)
- Volume 5, 2011 (40)
- Volume 4, 2010 (35)
- Volume 3, 2009 (27)
- Volume 2, 2008 (29)
- Volume 1, 2007 (1)
Archive: Volume 4, 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Corrigendum: Chimeric design, synthesis, and biological assays of a new nonpeptide insulin-mimetic vanadium compound to inhibit protein tyrosine phosphatase 1B
Scior T, Guevara-Garcia JA, Melendez FJ, et al
Drug Design, Development and Therapy 2010, 4:415-416
Published Date: 13 December 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease – a perspective
Richard Kones
Drug Design, Development and Therapy 2010, 4:383-413
Published Date: 9 December 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Profile of belatacept and its potential role in prevention of graft rejection following renal transplantation
Gaurav Gupta, Karl L Womer
Drug Design, Development and Therapy 2010, 4:375-382
Published Date: 1 December 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Comparative bioequivalence studies of tramadol hydrochloride sustained-release 200 mg tablets
Suhas S Khandave, Satish V Sawant, Santosh S Joshi, et al
Drug Design, Development and Therapy 2010, 4:367-374
Published Date: 25 November 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
New approaches in the management of multiple sclerosis
Laurie J Barten, Douglas R Allington, Kendra A Procacci, et al
Drug Design, Development and Therapy 2010, 4:343-366
Published Date: 24 November 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Adjunctive therapy for the treatment of primary generalized tonic-clonic seizures: focus on once-daily lamotrigine
Linda Steinbaugh, Jerzy P Szaflarski
Drug Design, Development and Therapy 2010, 4:337-342
Published Date: 18 November 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass
Ronald C Hamdy
Drug Design, Development and Therapy 2010, 4:321-335
Published Date: 18 November 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCG-refractory and BCG-intolerant patients
Mark Kowalski, Joycelyn Entwistle, Jeannick Cizeau, et al
Drug Design, Development and Therapy 2010, 4:313-320
Published Date: 15 November 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections
Emily Zoller, Connie Valente, Kyle Baker, et al
Drug Design, Development and Therapy 2010, 4:299-311
Published Date: 4 November 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Silodosin in the treatment of benign prostatic hyperplasia
Maxime Rossi, Thierry Roumeguère
Drug Design, Development and Therapy 2010, 4:291-297
Published Date: 27 October 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Liraglutide in the management of type 2 diabetes
Estela Wajcberg, Amatur Amarah
Drug Design, Development and Therapy 2010, 4:279-290
Published Date: 22 October 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy
Aarat M Patel, Larry W Moreland
Drug Design, Development and Therapy 2010, 4:263-278
Published Date: 1 October 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Thermosensitive Pluronic® hydrogel: prolonged injectable formulation for drug abuse
Katayoun Derakhshandeh, Mahtab Fashi, Seyedalireza Seifoleslami
Drug Design, Development and Therapy 2010, 4:255-262
Published Date: 20 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Current and developing therapeutic agents in the treatment of Chagas disease
Werner Apt
Drug Design, Development and Therapy 2010, 4:243-253
Published Date: 17 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Chimeric design, synthesis, and biological assays of a new nonpeptide insulin-mimetic vanadium compound to inhibit protein tyrosine phosphatase 1B
Thomas Scior, José Antonio Guevara-García, FJ Melendez, et al
Drug Design, Development and Therapy 2010, 4:231-242
Published Date: 23 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Safety and efficacy of azacitidine in myelodysplastic syndromes
Carlos E Vigil, Taida Martin-Santos, Guillermo Garcia-Manero
Drug Design, Development and Therapy 2010, 4:221-229
Published Date: 9 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
Son V Pham, Phuong-Chi T Pham, Phuong-Mai T Pham, et al.
Drug Design, Development and Therapy 2010, 4:203-220
Published Date: 6 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Emerging treatments in the management of schizophrenia – focus on sertindole
Maria Rosaria A Muscatello, Antonio Bruno, Gianluca Pandolfo, et al
Drug Design, Development and Therapy 2010, 4:187-201
Published Date: 24 August 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Development of QSAR model for immunomodulatory activity of natural coumarinolignoids
Dharmendra K Yadav, Abha Meena, Ankit Srivastava, et al
Drug Design, Development and Therapy 2010, 4:173-186
Published Date: 30 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy
Samuel L Washington III, Alan W Shindel
Drug Design, Development and Therapy 2010, 4:159-171
Published Date: 4 August 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD
Mark A Giembycz, Stephen K Field
Drug Design, Development and Therapy 2010, 4:147-158
Published Date: 14 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Eltrombopag – a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations
Lucy Cook, Nichola Cooper
Drug Design, Development and Therapy 2010, 4:139-145
Published Date: 29 June 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients
John Puetz
Drug Design, Development and Therapy 2010, 4:127-137
Published Date: 28 June 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine
Clemens Warnke, Heinz Wiendl, Hans-Peter Hartung, et al
Drug Design, Development and Therapy 2010, 4:117-126
Published Date: 18 June 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders
Pär I Johansson, Sisse R Ostrowski
Drug Design, Development and Therapy 2010, 4:107-116
Published Date: 29 June 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Development of a sublingual allergy vaccine for grass pollinosis
Franco Frati, Silvia Scurati, Paola Puccinelli, et al
Drug Design, Development and Therapy 2010, 4:99-105
Published Date: 17 June 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Emerging role of gefitinib in the treatment of non-small-cell lung cancer (NSCLC)
M Tiseo, M Bartolotti, F Gelsomino, et al
Drug Design, Development and Therapy 2010, 4:81-98
Published Date: 19 May 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
ACAM2000™: The new smallpox vaccine for United States Strategic National Stockpile
Aysegul Nalca, Elizabeth E Zumbrun
Drug Design, Development and Therapy 2010, 4:71-79
Published Date: 17 May 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension
Gautam V Ramani, Myung H Park
Drug Design, Development and Therapy 2010, 4:61-70
Published Date: 6 May 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
New anticoagulants for the prevention of venous thromboembolism
Cecilia Becattini, Alessandra Lignani, Giancarlo Agnelli
Drug Design, Development and Therapy 2010, 4:49-60
Published Date: 7 April 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
New atypical antipsychotics for schizophrenia: iloperidone
Silvio Caccia, Luca Pasina, Alessandro Nobili
Drug Design, Development and Therapy 2010, 4:33-48
Published Date: 15 February 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Continuation treatment of major depressive disorder: is there a case for duloxetine?
Trevor R Norman, James S Olver
Drug Design, Development and Therapy 2010, 4:19-31
Published Date: 12 February 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal
Chaouki K Khoury, James R Couch
Drug Design, Development and Therapy 2010, 4:9-17
Published Date: 25 January 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Corrigendum
Nusrat Motlekar, Bi-Botti Youan
Drug Design, Development and Therapy 2010, 4:7-8
Published Date: 26 January 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Recent advances in the treatment of premature ejaculation
Kate D Linton, Kevan R Wylie
Drug Design, Development and Therapy 2010, 4:1-6
Published Date: 5 January 2010